December 2, 2021
FHI Clinical announces its intent to acquire TCD Global, a South African-based CRO. The acquisition allows FHI Clinical to expand its share of the infectious disease (ID) clinical development market and become the dominant service provider in sub-Saharan Africa.
We manage complex clinical research in resource-limited settings
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
Stay two steps ahead with fhi clinical
Because of our global expertise, responsive approaches and proven solutions, we are two steps ahead, ready to deploy immediately in markets worldwide and able to measure study launch in days rather than weeks.
Reach new markets and access the right patient populations.
Benefit from our unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.
By connecting your research strategy with the overarching policy and local communities, we help facilitate communication and engagement efforts for more successful study execution.
As your study needs or the local situation change, we can adapt our processes and workflow. No matter how large or small the project, we remain agile and exact, because your research demands it.
We also invest in our intellectual capital and are experts at rapid start-up and management of complex clinical research at sites diverse in geographic area and research capacity.
Our work complements that of FHI 360, which is grounded in research and science, reinforced by partnerships and focused on strengthening the capacity of individuals, local organizations and national governments.
ensure equitable access to research
Together, we can ensure that countries are prepared to respond to threats to
their population’s health.
December 2, 2021
November 30 – December 2, 2021
Attending the World Vaccine and Immunotherapy Congress West Coast? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event.
Making sure CROs are prepared for the next iteration of ICH regulations was the topic of a recent webinar sponsored by Oracle. The expert panel featured FHI Clinical’s own Rob King, Chief Operating Officer, alongside executives from other organizations.